ANVISA registration

ADVIA Centaur anti-HBs2 (a-HBs2)

Registration 10345161824. ANTICORPO TOTAL PARA ANTÍGENO S DE VÍRUS DE HEPATITE B (ANTI-HBSAG)

Registration details

Registration number10345161824
Application number25351725730201084
Technical nameANTICORPO TOTAL PARA ANTÍGENO S DE VÍRUS DE HEPATITE B (ANTI-HBSAG)
Risk classIV
Published on28/11/2011
ValidityValid until 28/11/2026

Registration holder

Legal nameSIEMENS HEALTHCARE DIAGNÓSTICOS LTDA
CNPJ01.449.930/0001-90

Manufacturer

  • SIEMENS HEALTHCARE DIAGNOSTICS INC. ESTADOS UNIDOS DA AMÉRICA

Source: ANVISA

Source: ANVISA open data, medical device file, updated daily. The public database provides registration validity, rather than registration status: this registration may have been cancelled before its expiry date without this being shown here. Before making purchasing, import or marketing decisions, check the ANVISA search portal.

Next step

Medical device registration with ANVISA

HSC manages the process from risk classification to liaising with the regulator, in Brazil and more than 40 other countries.

Speak to a specialist